Bio X Cell, a leading supplier of functional antibodies, unveils a refreshed brand identity, highlighting its global leadership and expanded capabilities for preclinical research.
Bio X Cell is recognized worldwide as a leader in functional antibodies for in vivo and emerging preclinical models. The company has launched a refreshed brand identity. This milestone marks nearly 30 years of scientific leadership and innovation. Bio X Cell now pairs its legacy with expanded capabilities that support researchers across the entire preclinical research workflow.
Since its founding almost three decades ago, Bio X Cell has delivered high-quality functional antibody solutions. These products empower scientists in cancer, immunology, neuroscience, and infectious disease research. The company operates the world’s largest facility dedicated to manufacturing functional antibodies. It has a monthly throughput capacity of 2,000 liters. The upgraded facility is flexible, enabling the production of custom sizes and formulations. These are tailored for both in vivo animal studies and advanced in vitro models, including organoids and organs-on-chip.
Headquartered in the United States, Bio X Cell has expanded its global footprint with operations in China and Germany, supported by a robust network of distribution partners. This ensures that researchers around the world receive rapid and reliable access to Bio X Cell’s solutions.
The refreshed brand identity is more than a new logo and typeface. It shows Bio X Cell’s deepened commitment to supporting modern research in biopharma, academia, and biotech. The company is the only life science solutions provider offering 100% PhD-level technical support. Bio X Cell is cited in nearly 30,000 peer-reviewed publications. The new identity aligns the company with the latest scientific advancements. These range from classic in vivo models to next-generation platforms such as New Alternative Methods (NAM), organoids, spheroids, and organ-on-a-chip systems.
Bio X Cell is expanding its catalog to include modern antibody solutions. These include bispecifics and antibody-drug conjugates (ADCs). The company also offers workflow solutions that bridge high-throughput NAM studies with complex in vivo models. Custom services allow researchers to scale and customize RUO-grade antibodies from milligrams to grams. This supports projects of any size.
Christopher Conway, CEO of Bio X Cell, emphasizes the company’s commitment:
“Building on our heritage as a trusted provider of ultra-pure, functional antibodies, we are expanding our capabilities to meet the needs of cutting-edge research models from advanced NAM platforms and organoids to complex in vivo studies. Backed by PhD-level expertise, our antibody solutions combine scientific rigor with innovative formulation and scalable capacity, ensuring precise, reproducible, and translatable results.”
Bio X Cell’s refreshed brand identity represents both its legacy and its vision for the future. The company embraces expansion, innovation, and global reach. It remains focused on empowering translational research. Bio X Cell continues to be a trusted partner for scientists at the forefront of discovery. The company delivers antibody solutions that move science forward.
Learn more about Bio X Cell and explore their products:
We gladly support you by keeping you updated on our latest products and the developments around our services.
Direct contact technical support
Find products for your research
